Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Go back to Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology| (NASDAQ: DFTX) | Delayed: 43.67 -1.41 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.08 | 52 Week High | $ | |||
| Open | $44.02 | 52 Week Low | $ | |||
| Day High | $44.99 | P/E | N/A | |||
| Day Low | $43.53 | EPS | $ | |||
| Volume | 1,239,538 | |||||
